Auxogyn teams with Merck Serono on in vitro fertilization embryo test

Auxogyn Inc. made a deal with Merck Serono for advice and support in developing and marketing a test for embryos during in vitro fertilization.

Menlo Park-based Auxogyn and Darmstadt, Germany's Merck Serono will work together on the Early Embryo Viability Assessment, or Eeva Test. It was approved in July by European regulators -- getting the CE mark which allows it to be sold in the European Union -- and it is pending before the U.S. Food and Drug Administration.